[Reduce the dosage of ketorolac! Following EEC recommendations reduces the risk of hemorrhage with a marginal reduction of the analgesic effect].
Lagerkranser
M
M
Anestesi- och intensivvårdskliniken, Karolinska sjukhuset.
Belfrage
M
M
Flordal
P A
PA
Persson
E
E
D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage* / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005062:European Union; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D020910:Ketorolac; D014046:Tolmetin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D018712:Analgesics, Non-Narcotic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D014046:Tolmetin; D020910:Ketorolac